Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2015

Open Access 01-12-2015 | Research article

Anti-inflammatory effects of Hwang-Heuk-San, a traditional Korean herbal formulation, on lipopolysaccharide-stimulated murine macrophages

Authors: Hye Joo Kang, Su Hyun Hong, Kyung-Hwa Kang, Cheol Park, Yung Hyun Choi

Published in: BMC Complementary Medicine and Therapies | Issue 1/2015

Login to get access

Abstract

Background

Hwang-Heuk-San (HHS), a Korean traditional herbal formula comprising four medicinal herbs, has been used to treat patients with inflammation syndromes and digestive tract cancer for hundreds of years; however, its anti-inflammatory potential is poorly understood. The aim of the present study was to investigate the anti-inflammatory effects of HHS using a lipopolysaccharide (LPS)-activated RAW 264.7 macrophage model.

Methods

The inhibitory effects of HHS on LPS-induced nitric oxide (NO), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) production were examined using Griess reagent and enzyme-linked immunosorbent assay (ELISA) detection kits. The effects of HHS on the expression of inducible NO synthase (iNOS), IL-1β and TNF-α, their upstream signal proteins, including nuclear factor κB (NF-κB), mitogen-activated protein kinases (MAPKs), and activator protein (AP-1), were also investigated.

Results

A noncytotoxic concentration of HHS significantly reduced the production of NO, IL-1β and TNF-α in LPS-stimulated RAW 264.7 cells, which was correlated with reduced expression of iNOS, IL-1β and TNF-α at the mRNA and protein levels. HHS efficiently blocked the phosphorylation of MAPKs, especially that of extracellular signal-regulated kinase (ERK) and c-Jun NH2-terminal kinase (JNK) but not that of the p38 MAPK. The reduced production of inflammatory molecules by HHS was followed by decreased activity of NF-κB and AP-1.

Conclusions

These results suggest that HHS may offer therapeutic potential for treating inflammatory diseases accompanied by macrophage activation.
Literature
1.
go back to reference Laveti D, Kumar M, Hemalatha R, Sistla R, Naidu VG, Talla V, et al. Anti-inflammatory treatments for chronic diseases: a review. Inflamm Allergy Drug Targets. 2013;12:349–61.CrossRefPubMed Laveti D, Kumar M, Hemalatha R, Sistla R, Naidu VG, Talla V, et al. Anti-inflammatory treatments for chronic diseases: a review. Inflamm Allergy Drug Targets. 2013;12:349–61.CrossRefPubMed
3.
go back to reference Roberts-Thomson IC, Fon J, Uylaki W, Cummins AG, Barry S. Cells, cytokines and inflammatory bowel disease: a clinical perspective. Expert Rev Gastroenterol Hepatol. 2011;5:703–16.CrossRefPubMed Roberts-Thomson IC, Fon J, Uylaki W, Cummins AG, Barry S. Cells, cytokines and inflammatory bowel disease: a clinical perspective. Expert Rev Gastroenterol Hepatol. 2011;5:703–16.CrossRefPubMed
4.
go back to reference Norberg JK, Sells E, Chang HH, Alla SR, Zhang S, Meuillet EJ. Targeting inflammation: multiple innovative ways to reduce prostaglandin E2. Pharm Pat Anal. 2013;2:265–88.CrossRefPubMedPubMedCentral Norberg JK, Sells E, Chang HH, Alla SR, Zhang S, Meuillet EJ. Targeting inflammation: multiple innovative ways to reduce prostaglandin E2. Pharm Pat Anal. 2013;2:265–88.CrossRefPubMedPubMedCentral
5.
go back to reference Joubert J, Malan SF. Novel nitric oxide synthase inhibitors: a patent review. Expert Opin Ther Pat. 2011;21:537–60.CrossRefPubMed Joubert J, Malan SF. Novel nitric oxide synthase inhibitors: a patent review. Expert Opin Ther Pat. 2011;21:537–60.CrossRefPubMed
6.
go back to reference Hatziieremia S, Gray AI, Ferro VA, Paul A, Plevin R. The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages. Br J Pharmacol. 2006;149:188–98.CrossRefPubMedPubMedCentral Hatziieremia S, Gray AI, Ferro VA, Paul A, Plevin R. The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages. Br J Pharmacol. 2006;149:188–98.CrossRefPubMedPubMedCentral
7.
go back to reference Schonthaler HB, Guinea-Viniegra J, Wagner EF. Targeting inflammation by modulating the Jun/AP-1 pathway. Ann Rheum Dis. 2011;70 Suppl 1:i109–12.CrossRefPubMed Schonthaler HB, Guinea-Viniegra J, Wagner EF. Targeting inflammation by modulating the Jun/AP-1 pathway. Ann Rheum Dis. 2011;70 Suppl 1:i109–12.CrossRefPubMed
8.
go back to reference Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, et al. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther. 2008;10:201.CrossRefPubMedPubMedCentral Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, et al. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther. 2008;10:201.CrossRefPubMedPubMedCentral
9.
go back to reference Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM, et al. Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB. J Cell Mol Med. 2008;12:316–29.CrossRefPubMed Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM, et al. Expression of the NF-kappaB inhibitor ABIN-3 in response to TNF and toll-like receptor 4 stimulation is itself regulated by NF-kappaB. J Cell Mol Med. 2008;12:316–29.CrossRefPubMed
10.
go back to reference Lucas K, Maes M. Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol Neurobiol. 2013;48:190–204.CrossRefPubMed Lucas K, Maes M. Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol Neurobiol. 2013;48:190–204.CrossRefPubMed
11.
go back to reference Gasparini C, Feldmann M. NF-κB as a target for modulating inflammatory responses. Curr Pharm Des. 2012;18:5735–45.CrossRefPubMed Gasparini C, Feldmann M. NF-κB as a target for modulating inflammatory responses. Curr Pharm Des. 2012;18:5735–45.CrossRefPubMed
12.
go back to reference Casals-Casas C, Alvarez E, Serra M, de la Torre C, Farrera C, Sánchez-Tilló E, et al. CREB and AP-1 activation regulates MKP-1 induction by LPS or M-CSF and their kinetics correlate with macrophage activation versus proliferation. Eur J Immunol. 2009;39:1902–13.CrossRefPubMed Casals-Casas C, Alvarez E, Serra M, de la Torre C, Farrera C, Sánchez-Tilló E, et al. CREB and AP-1 activation regulates MKP-1 induction by LPS or M-CSF and their kinetics correlate with macrophage activation versus proliferation. Eur J Immunol. 2009;39:1902–13.CrossRefPubMed
13.
go back to reference Patterson H, Nibbs R, McInnes I, Siebert S. Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases. Clin Exp Immunol. 2014;176:1–10.CrossRefPubMedPubMedCentral Patterson H, Nibbs R, McInnes I, Siebert S. Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases. Clin Exp Immunol. 2014;176:1–10.CrossRefPubMedPubMedCentral
14.
go back to reference Sucher NJ. The application of Chinese medicine to novel drug discovery. Expert Opin Drug Discov. 2013;8:21–34.CrossRefPubMed Sucher NJ. The application of Chinese medicine to novel drug discovery. Expert Opin Drug Discov. 2013;8:21–34.CrossRefPubMed
15.
go back to reference Teschke R, Wolff A, Frenzel C, Schulze J. Review article: Herbal hepatotoxicity--an update on traditional Chinese medicine preparations. Aliment Pharmacol Ther. 2014;40:32–50.CrossRefPubMed Teschke R, Wolff A, Frenzel C, Schulze J. Review article: Herbal hepatotoxicity--an update on traditional Chinese medicine preparations. Aliment Pharmacol Ther. 2014;40:32–50.CrossRefPubMed
16.
go back to reference Park H, Kim HS. Korean traditional natural herbs and plants as immune enhancing, antidiabetic, chemopreventive, and antioxidative agents: a narrative review and perspective. J Med Food. 2014;17:21–7.CrossRefPubMed Park H, Kim HS. Korean traditional natural herbs and plants as immune enhancing, antidiabetic, chemopreventive, and antioxidative agents: a narrative review and perspective. J Med Food. 2014;17:21–7.CrossRefPubMed
17.
go back to reference Kumar H, Song SY, More SV, Kang SM, Kim BW, Kim IS, et al. Traditional Korean East Asian medicines and herbal formulations for cognitive impairment. Molecules. 2013;18:14670–93.CrossRefPubMed Kumar H, Song SY, More SV, Kang SM, Kim BW, Kim IS, et al. Traditional Korean East Asian medicines and herbal formulations for cognitive impairment. Molecules. 2013;18:14670–93.CrossRefPubMed
18.
go back to reference Lee KP, Sudjarwo GW, Kim JS, Dirgantara S, Maeng WJ, Hong H. The anti-inflammatory effect of Indonesian Areca catechu leaf extract in vitro and in vivo. Nutr Res Pract. 2014;8:267–71.CrossRefPubMedPubMedCentral Lee KP, Sudjarwo GW, Kim JS, Dirgantara S, Maeng WJ, Hong H. The anti-inflammatory effect of Indonesian Areca catechu leaf extract in vitro and in vivo. Nutr Res Pract. 2014;8:267–71.CrossRefPubMedPubMedCentral
19.
go back to reference Hwang YJ, Song J, Kim HR, Hwang KA. Oleanolic acid regulates NF-κB signaling by suppressing MafK expression in RAW 264.7 cells. BMB Rep. 2014;47:524–9.CrossRefPubMedPubMedCentral Hwang YJ, Song J, Kim HR, Hwang KA. Oleanolic acid regulates NF-κB signaling by suppressing MafK expression in RAW 264.7 cells. BMB Rep. 2014;47:524–9.CrossRefPubMedPubMedCentral
20.
go back to reference Jeong MH, Yang K, Lee CG, Jeong DH, Park YS, Choi YJ, et al. In vitro genotoxicity assessment of a novel resveratrol analogue, HS-1793. Toxicol Res. 2014;30:211–20.CrossRefPubMedPubMedCentral Jeong MH, Yang K, Lee CG, Jeong DH, Park YS, Choi YJ, et al. In vitro genotoxicity assessment of a novel resveratrol analogue, HS-1793. Toxicol Res. 2014;30:211–20.CrossRefPubMedPubMedCentral
21.
go back to reference Kim BH, Oh I, Kim JH, Jeon JE, Jeon B, Shin J, et al. Anti-inflammatory activity of zcompounds isolated from Astragalus sinicus L. in cytokine-induced keratinocytes and skin. Exp Mol Med. 2014;46:e87.CrossRefPubMedPubMedCentral Kim BH, Oh I, Kim JH, Jeon JE, Jeon B, Shin J, et al. Anti-inflammatory activity of zcompounds isolated from Astragalus sinicus L. in cytokine-induced keratinocytes and skin. Exp Mol Med. 2014;46:e87.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J Leukoc Biol. 2010;88:1157–62.CrossRefPubMed Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J Leukoc Biol. 2010;88:1157–62.CrossRefPubMed
24.
go back to reference Mobasheri A, Shakibaei M. Is tendinitis an inflammatory disease initiated and driven by pro-inflammatory cytokines such as interleukin 1β? Histol Histopathol. 2013;28:955–64.PubMed Mobasheri A, Shakibaei M. Is tendinitis an inflammatory disease initiated and driven by pro-inflammatory cytokines such as interleukin 1β? Histol Histopathol. 2013;28:955–64.PubMed
25.
go back to reference Broom OJ, Widjaya B, Troelsen J, Olsen J, Nielsen OH. Mitogen activated protein kinases: a role in inflammatory bowel disease? Clin Exp Immunol. 2009;158:272–80.CrossRefPubMedPubMedCentral Broom OJ, Widjaya B, Troelsen J, Olsen J, Nielsen OH. Mitogen activated protein kinases: a role in inflammatory bowel disease? Clin Exp Immunol. 2009;158:272–80.CrossRefPubMedPubMedCentral
26.
go back to reference Debnath T, Kim Da H, Lim BO. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease. Molecules. 2013;18:7253–70.CrossRefPubMed Debnath T, Kim Da H, Lim BO. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease. Molecules. 2013;18:7253–70.CrossRefPubMed
27.
go back to reference Ivashkiv LB. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Barnes PJ. Nuclear factor-kappa B. Int J Biochem Cell Biol. 1997;29:867–70.CrossRef Ivashkiv LB. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Barnes PJ. Nuclear factor-kappa B. Int J Biochem Cell Biol. 1997;29:867–70.CrossRef
28.
go back to reference Lan W, Petznick A, Heryati S, Rifada M, Tong L. Nuclear Factor-κB: central regulator in ocular surface inflammation and diseases. Ocul Surf. 2012;10:137–48.CrossRefPubMed Lan W, Petznick A, Heryati S, Rifada M, Tong L. Nuclear Factor-κB: central regulator in ocular surface inflammation and diseases. Ocul Surf. 2012;10:137–48.CrossRefPubMed
Metadata
Title
Anti-inflammatory effects of Hwang-Heuk-San, a traditional Korean herbal formulation, on lipopolysaccharide-stimulated murine macrophages
Authors
Hye Joo Kang
Su Hyun Hong
Kyung-Hwa Kang
Cheol Park
Yung Hyun Choi
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2015
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-015-0971-2

Other articles of this Issue 1/2015

BMC Complementary Medicine and Therapies 1/2015 Go to the issue